Eventide Asset Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-140,000
Closed -$2.45M 145
2018
Q1
$2.45M Hold
140,000
0.11% 108
2017
Q4
$3.45M Hold
140,000
0.18% 90
2017
Q3
$3.61M Hold
140,000
0.2% 85
2017
Q2
$3.8M Hold
140,000
0.24% 80
2017
Q1
$4.18M Sell
140,000
-80,000
-36% -$2.39M 0.28% 76
2016
Q4
$5.97M Buy
220,000
+80,000
+57% +$2.17M 0.39% 65
2016
Q3
$3.59M Buy
+140,000
New +$3.59M 0.22% 79